Table 3.
Group | Middle aged | Younger old | Older old | Female | Male |
---|---|---|---|---|---|
EXG | + 7.4 (5.7) | + 34.6 (8.2) | + 3.2 (9.4) | + 23.9 (7.0) | + 6.2 (5.7) |
CNG | − 2.8 (10.9) | − 20.1 (7.7) | − 7.6 (7.1) | − 23.6 (7.1) | + 3.3 (6.9) |
Mean difference | 10.2 (12.3) | 54.7* (11.2) | 10.8 (11.8) | 47.5* (9.9) | 3.0 (8.9) |
95% CI | − 14.5 to + 35.0 | + 32.2 to + 77.1 | − 12.8 to + 34.4 | + 27.7 to + 67.3 | − 14.9 to + 20.8 |
Data are presented as means (relative changes in muscle function) and standard deviations. EXG, experimental group; CNG, control group. p-value calculated for intention-to-treat analysis (n = 90, nEXG = 57, nCNG = 33). Difference between groups significant at p < 0.001 is marked by *.